EUVIMEDEUVIMED entdecken
Editorial

Editorial: Personalising the Low FODMAP Diet to Achieve Therapeutic Benefit Whilst Reducing Burden and Maintaining Dietary Diversity in Irritable Bowel Syndrome

Kevin Whelan iD

Alimentary Pharmacology & Therapeutics · 2026-06 · 63 (11) · 1557-1558

DOI: 10.1111/apt.70626 ↗

Kurz gefasst

Editorial in der Zeitschrift Alimentary Pharmacology & Therapeutics, online erschienen am 25.03.2026. Verfasst von Kevin Whelan. Beteiligte Einrichtung: King's College London, Department of Nutritional Sciences, London, UK. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 9 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

FODMAPsclinical trialsdietirritable bowel syndrome

Autor:innen und Institutionen

  • King's College London, Department of Nutritional Sciences, London, UK.

ORCID-Profile: Kevin Whelan

Zitieren

APA

Whelan, K. (2026). Editorial: Personalising the Low FODMAP Diet to Achieve Therapeutic Benefit Whilst Reducing Burden and Maintaining Dietary Diversity in Irritable Bowel Syndrome. Alimentary Pharmacology & Therapeutics, 63(11), 1557-1558. https://doi.org/10.1111/apt.70626

Vancouver

Whelan K. Editorial: Personalising the Low FODMAP Diet to Achieve Therapeutic Benefit Whilst Reducing Burden and Maintaining Dietary Diversity in Irritable Bowel Syndrome. Alimentary Pharmacology & Therapeutics. 2026;63(11):1557-1558. doi:10.1111/apt.70626

BibTeX
@article{Whelan2026,
  author = {Whelan, Kevin},
  title = {Editorial: Personalising the Low FODMAP Diet to Achieve Therapeutic Benefit Whilst Reducing Burden and Maintaining Dietary Diversity in Irritable Bowel Syndrome},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  volume = {63},
  number = {11},
  pages = {1557--1558},
  doi = {10.1111/apt.70626}
}
Kostenlos starten →